Man Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Man Group's BMY Position: Q2 2026 in Review
Man Group reduced its Bristol-Myers Squibb (BMY) stake by 17% in Q2 2026, selling an estimated $56.1M and leaving 4,682,000 shares worth $270M. The position accounts for 0.43% of the portfolio, ranked #44.
Man Group first reported a position in BMY in Q1 2018 and has held it in 31 quarters since. The position peaked at $449M in Q4 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Man Group held 4,682,000 shares of Bristol-Myers Squibb worth $270M as of Q2 2026.
- Man Group sold 976,497 Bristol-Myers Squibb shares in Q2 2026, an estimated $56.1M.
- Bristol-Myers Squibb made up 0.43% of Man Group's portfolio in Q2 2026, its #44 holding.
- Man Group first reported a position in Bristol-Myers Squibb in Q1 2018 and has held it in 31 quarters since.
- Man Group's Bristol-Myers Squibb position peaked at $449M in Q4 2025.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.